Close

Form 8-K MICROVISION, INC. For: Mar 11

March 11, 2021 4:08 PM EST
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________

Form 8-K
_____________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event Reported): March 11, 2021  

MICROVISION, INC.
(Exact Name of Registrant as Specified in Charter)

Delaware001-3417091-1600822
(State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification Number)

6244 185th Avenue NE, Suite 100
Redmond, Washington 98052
(Address of Principal Executive Offices) (Zip Code)

(425) 936-6847
(Registrant's telephone number, including area code)

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 [   ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 [   ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 [   ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 [   ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading
Symbol(s)
 Name of each exchange
on which registered
Common Stock, $0.001 par value per share MVIS The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company [   ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [   ]

 

 
 

Item 2.02. Results of Operations and Financial Condition.

The information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

On March 11, 2021, MicroVision, Inc. issued a press release announcing its Fourth Quarter and Full Year 2020 results. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(c) Exhibits.

99.1 MicroVision, Inc. Press Release Announces Fourth Quarter and Full Year 2020 Results.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 MICROVISION, INC.
   
  
Date: March 11, 2021By: /s/ David J. Westgor        
  David J. Westgor
  Vice President, General Counsel & Secretary
  

EXHIBIT 99.1

MicroVision Announces Fourth Quarter and Full Year 2020 Results

REDMOND, Wash., March 11, 2021 (GLOBE NEWSWIRE) -- MicroVision, Inc. (NASDAQ: MVIS), a leader in MEMS based solid state automotive lidar and micro-display technology for augmented reality, today announced its fourth quarter and full year 2020 results.

“Over the past year we have made important progress advancing our automotive LiDAR development, bolstering our balance sheet, building the strength of our team, and adding expertise to our Board of Directors while exploring strategic alternatives,” said Sumit Sharma, MicroVision's Chief Executive Officer. “I expect that the A-Sample hardware and benchmarked data, for demonstration to interested parties, will be available in the April 2021 timeframe. I also expect that a version of our 1st generation Long Range Lidar sensor, after internal validation, reliability and compliance testing, could be available for sale, in small quantities, in the third or fourth quarter of 2021.”

Financial Results Webcast

MicroVision will host a webcast which will start at 2:00 p.m. Pacific Time on Thursday, March 11, 2021 by accessing the Investor Relations section of MicroVision’s website on the Investor Relations Events Calendar page at https://microvision.gcs-web.com/investor-event-calendar. Investors may submit questions for management in advance to [email protected] or beginning 10 minutes before or during the live webcast on March 11, 2021. The webcast will be available for rebroadcast from the Investor Relations section of MicroVision’s website on the Investor Relations Events Calendar page.

About MicroVision

MicroVision is a pioneering company in MEMS based laser beam scanning technology that integrates MEMS, lasers, optics, hardware, algorithms and machine learning software into its proprietary technology to address existing and emerging markets. The Company’s integrated approach uses its proprietary technology to provide solutions for automotive lidar sensors, augmented reality micro-display engines, interactive display modules and consumer lidar modules.

For more information, visit the Company’s website at www.microvision.com, on Facebook at www.facebook.com/microvisioninc or follow MicroVision on Twitter at @MicroVision.
MicroVision is a trademark of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.

Forward-Looking Statements

Certain statements contained in this release, including the Company’s future products, progress on development, pursuit of a strategic transaction, and product applications and statements using words such as “expect” and “could” are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking statements include the risk that the Company may not succeed in finding licensing or other strategic solutions, including a potential sale of the Company, with acceptable timing, benefits or costs; its ability to operate with limited cash or to raise additional capital when needed; market acceptance of its technologies and products or for products incorporating its technologies; the failure of its commercial partners to perform as expected under its agreements, including from the impact of COVID-19 (coronavirus); its ability to identify parties interested in paying any amounts or amounts that the Company deems desirable for the purchase or license of intellectual property assets; its or its customers’ failure to perform under open purchase orders; its financial and technical resources relative to those of its competitors; its ability to keep up with rapid technological change; government regulation of its technologies; its ability to enforce its intellectual property rights and protect its proprietary technologies; the ability to obtain additional contract awards and develop partnership opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market its products; potential product liability claims; its ability to maintain its listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company's SEC reports, including the Company's Annual Report on Form 10-K filed with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect the Company to a greater extent than indicated. Except as expressly required by federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.

 
MicroVision, Inc. 
Balance Sheet 
(In thousands) 
(Unaudited) 
  December 31,  December 31, 
  2020  2019 
       
Assets      
Current Assets      
Cash and cash equivalents $16,862  $5,837 
Accounts receivable -  1,079 
Inventory -  192 
Other current assets 698  729 
Total current assets 17,560  7,837 
       
Property and equipment, net 1,883  1,849 
Operating lease right-of-use asset 946  1,308 
Restricted cash 435  435 
Intangible assets, net 164  221 
Other assets 18  186 
Total assets $21,006  $11,836 
       
       
Liabilities and Shareholders' Equity (Deficit)      
Current Liabilities      
Accounts payable $ 630  $ 1,871 
Accrued liabilities 495  2,045 
Deferred revenue -  21 
Contract liabilities 7,765  9,755 
Other current liabilities -  83 
Current portion of long-term debt 431  - 
Current portion of operating lease liability 676  656 
Current portion of finance lease obligations 31  25 
Total current liabilities 10,028  14,456 
       
Long term debt, net of current portion 1,151  - 
Operating lease liability, net of current portion 774  1,348 
Finance lease obligations, net of current portion 44  9 
Total liabilities 11,997  15,813 
       
Commitments and contingencies      
       
Shareholders' Equity (Deficit)      
Common stock at par value 153  126 
Additional paid-in capital 601,224  568,496 
Subscriptions receivable  (6,135) - 
Accumulated deficit  (586,233)  (572,599)
Total shareholders' equity (deficit) 9,009  (3,977
Total liabilities and shareholders' equity (deficit) $21,006  $11,836 
       


MicroVision, Inc.
Statement of Operations
(In thousands, except earnings per share data)
(Unaudited)
         
  Three months ended December 31,   Twelve months ended December 31, 
   2020   2019   2020   2019 
         
         
Product revenue $-  $4,147  $1,347  $5,345 
License and royalty revenue  395   82   1,718   99 
Contract revenue  -   376   25   3,442 
Total revenue  395   4,605   3,090   8,886 
         
Cost of product revenue  -   3,340   1,394   6,692 
Cost of contract revenue  -   86   4   1,872 
Total cost of revenue  -   3,426   1,398   8,564 
         
Gross margin  395   1,179   1,692   322 
         
         
Research and development expense  2,578   3,177   9,840   18,661 
Sales, marketing, general and administrative expense  1,381   1,282   5,917   8,133 
Gain on disposal of fixed assets  -   -   (450)  - 
Total operating expenses  3,959   4,459   15,307   26,794 
         
         
Loss from operations  (3,564)  (3,280)  (13,615)  (26,472)
         
Other expense, net  (6)  (4)  (19)  (11)
         
Net income (loss) $(3,570) $(3,284) $(13,634) $(26,483)
         
Net income (loss) per share - basic and diluted $(0.02) $(0.03) $(0.10) $(0.24)
         
Weighted-average shares outstanding - basic and diluted  148,176   121,220   139,829   111,297 
         

Investor Relations Contact

David H. Allen
Darrow Associates, Inc.
408.427.4463
[email protected]



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings